Filter
381
Text search:
virus
variants
Featured
Recommendations
69
New Publications
26
Language
Document type
Guidelines
115
Studies & Reports
80
No document type
59
Fact sheets
46
Strategic & Response Plan
31
Manuals
23
Training Material
8
Videos
8
Resource Platforms
5
Situation Updates
3
Brochures
2
Infographics
1
Countries / Regions
Global
23
Latin America and the Carribbean
16
Africa
13
India
9
Western and Central Europe
8
Germany
7
Kenya
7
Brazil
7
South Africa
5
East and Southern Africa
5
West and Central Africa
5
Nigeria
4
Niger
4
Malawi
4
Middle East and North Africa
4
Russia
4
Senegal
3
Congo, Democratic Republic of
3
Ethiopia
3
Cameroon
3
South Sudan
3
South–East Asia Region
3
Eastern Europe
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Uganda
2
Haiti
2
Lebanon
2
Turkey
2
Syria
2
Chad
2
Rwanda
2
Mozambique
2
Sudan
2
Peru
2
Bolivia
2
Chile
2
Asia
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Ghana
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Egypt
1
Mauritania
1
Benin
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Gabon
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
95
Clinical Guidelines
31
Public Health
16
Key Resources
14
Pharmacy & Technologies
12
Women & Child Health
7
Capacity Building
3
Toolboxes
COVID-19
218
HIV
22
Rapid Response
19
Planetary Health
11
NTDs
11
2.0 Rapid Response
9
TB
8
Ebola & Marburg
7
Health Financing Toolbox
7
AMR
6
Global Health Education
5
Mental Health
4
NCDs
4
Malaria
4
Caregiver
3
Refugee
2
Pharmacy
2
Cholera
1
Polio
1
Conflict
1
Zika
1
Specific Hazards
1
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv
...
Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera
...
Vaccines explained
recommended
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
Availble in different languages
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Nature | Vol 600 | 2 December 2021 |
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Les notes d’orientation exposent les mesures essentielles que les décideurs peuvent mettre en œuvre aux niveaux national et infranational pour les éléments suivants : tests de diagnostic de la COVID-19, prise en charge clinique de la COVID-19, atteinte des cibles en matière de vaccination con
...
Updated 25 January 2021
